Seed VC · USA

TGC

Active

What they invest in

TCG is a venture ecosystem dedicated to fueling scientific innovation in the life sciences industry, deploying an edge-to-edge investment model that propels early technology platforms, single assets and later-stage programs forward from inception through exit.

Who they back

DeepTechHealthtechBiotechSeedSeries ASeries B+

Business models

biotech_therapeutics, deeptech_ip

Customer segments

Researchers, Enterprise

Geography

US

Recent investments

  • Neurona Therapeutics
  • Accent Therapeutics
  • Remix Therapeutics

+ 2 more deals. Score your deck to see the full investment history.

The people who write checks

11 partners on file at TGC, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

TGC writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks TGC alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
United States
Last known deal
Dec 2019
Portfolio last checked
Oct 6, 2026
Website
www.thecolumngroup.com ↗

Other firms investing in DeepTech

See all investors

Is TGC the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. TGC is one of them, and we'll tell you exactly where they sit in your top 100.